Q2 2021

Source filing unavailable

Q2 2021 · —

Revenue—

Net Income

$2.90B

+55.1% vs Q2 2020

EPS Diluted

$1.28

+58.0% vs Q2 2020

Gross Profit$9,380,000,000+14.5%

Operating Income$3,479,000,000+47.9%

Operating Cash Flow$4,132,000,000+4.3%

Same quarter

Metric	Q2 2021	Q2 2020	Q2 2019	Q2 2018
Net Income	$2.90B	$1.87B	$6.80B	$7.77B
EPS Diluted	$1.28	$0.81	$2.91	$3.31

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Novartis AG · CIK 1114448 · Engraved from SEC EDGAR